Weight changes in type 2 diabetes and the impact of gender

Diabetes, Obesity and Metabolism

Volumn 10, Issue 9, 2008, Pages 726-732

  Tuthill, Antoinette ^a,b   McKenna, M J ^a   O'Shea, D ^a   McKenna, T J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Glycaemic control; Type 2 diabetes mellitus; Weight gain

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; COMBINATION CHEMOTHERAPY; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 50249184051     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00800.x     Document Type: Article

References (24)

1. McCarthy SN, Gibney MJ, Flynn A, Livingstone MBE, for the Irish Universities Nutrition Alliance. Overweight, obesity and physical activity levels in Irish adults: Evidence from the North/South Ireland Food Consumption Survey. Proc Nutr Soc 2002; 61: 3-7.
2. World Health Organisation. Preventing and Managing the Global Epidemic. Geneva: WHO, 1998.
3. Field AE, Manson JE, Laird N, Williamson DF, Willett WC, Colditz GA. Weight cycling and the risk of developing type 2 diabetes among adult women in the United States. Obes Res 2004; 12: 267-274.
4. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
5. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
8. Chaudhry ZW, Gannon MC, Nuttall FQ. Stability of body weight in type 2 diabetes. Diabetes Care 2006; 29: 493-497.
9. Jacob AN, Salinas K, Adams-Huet B, Raskin P. Weight gain in type 2 diabetes mellitus. Diabetes Obes Metab 2007; 9: 386-393.
10. Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 1986; 35: 155-164.
11. Wing RR, Marcus MD, Epstein LH, Salata R. Type 2 diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987; 10: 563-566.
12. Fujioka K, Seaton TB, Rowe E et al. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab 2000; 2: 175-187.
13. Seidell JC, Deerenberg I. Obesity in Europe: Prevalence and consequences for use of medical care. Pharmacoeconomics 1994; 5: 38-44.
14. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998; 6: 97-106.
15. Jacobson AM, De Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes. Diabetes Care 1994; 17: 267-274.
16. Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997; 20: 299-305.
17. U.S. Department of Health and Human Services. Incidence of Diabetes. Data from the National Health Interview Survey. Atlanta, GA: Centers for Disease Control and Prevention, 2004.
18. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499-1504.
19. Heitmann BL, Garby L. Patterns of long-term weight changes in overweight developing Danish men and women aged between 30 and 60 years. Int J Obes 1999; 23: 1074-1078.
20. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight? JAMA 1999; 282: 1576-1578.
21. Chan WB, Chan JCN, Chow CC et al. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education. Q J Med 2000; 93: 183-190.
22. Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 2001; 24: 1917-1922.
23. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type 2 diabetes mellitus. Diabetologia 1999; 42: 406-412.
24. Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P, Braatvedt GD. The influences of obesity and glycaemic control on endothelial activation in patients with type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 5491-5497.